Also known as: M.I.T., MIT
MIT engineers trained a language model on yeast codon usage to design genes that boost protein production, outperforming commercial tools for five of six proteins. The approach could lower drug development costs by improving yields of protein-based medicines.
New 3D brain tissue models, laser imaging, and organoid sensors aim to speed drug development for Alzheimer’s and other neurological diseases. The LMU model replicates Alzheimer’s aggregates, MIT’s laser images the blood-brain barrier at record speed, and UNC’s sensor records neural activity without damaging organoids.
More than 80% of U.S. physicians use AI in their work. AI is revealing new cardiac biomarkers and speeding drug discovery, with the healthcare AI market projected to reach $505.6 billion by 2033—but studies warn of bias and eroding critical thinking.
A federal judge blocked grant terminations based on changed priorities; OMB proposes political control over awards. Ph.D. enrollment declines as funding uncertainty persists, and science leaders urge advocacy.
Portal Biotechnologies closes $9M funding round to expand cell engineering platform for drug discovery and cell therapy. Navikenz raises $7.5M seed round to scale AI transformation services focused on life sciences and pharmaceuticals.
New studies show how mRNA fragments activate backup genes, how RISC assembly uses target mRNA, and how Rrm4 transports mRNA in fungi — pointing to new therapeutic approaches.
MIT chemical engineers used a large language model to optimize protein production in industrial yeast. The AI model improved yields for five of six tested proteins, including a cancer monoclonal antibody, potentially reducing drug development costs.
Dewpoint Therapeutics has initiated a Phase 1a/2a clinical trial for DPTX3186, a first-in-class therapy targeting biomolecular condensates in advanced solid tumors. The drug's development is based on foundational research from Whitehead Institute on cellular organization and gene regulation. The trial represents an early clinical evaluation of condensate-based therapeutics for cancer treatment.
Trump administration cuts to U.S. science funding have raised fears of a brain drain, with thousands of grants cancelled and researchers moving abroad. Experts warned the losses could damage biomedical innovation and the economy.
Bayer achieved its upgraded 2025 financial targets with group sales reaching 45.6 billion euros and projects solid 2026 performance. The company's pharmaceutical business shows rejuvenation with launch medicines becoming growth drivers, while Crop Science progresses in profitability improvement. Bayer continues strategic diversification in oncology and addresses litigation challenges while implementing cost-saving measures.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07744425 |
Shortwave Infrared Surgical Imaging Device Study |
ENROLLING_BY_INVITATION | |
| NCT07676474 |
Continuous Wireless Ultrasound to Monitor Fetal Health |
NOT_YET_RECRUITING | |
| NCT07652437 |
Study of Wearable Interventions for Improving Mobility of Individuals With Knee Osteoarthritis |
RECRUITING | NA |
| NCT07645729 |
Evaluation of a Powered Ankle Prosthesis Capable of Bidirectional Control Via Neural Recording and Cutaneous Stimulation in Free-Space and Walking Tasks |
RECRUITING | NA |
| NCT07615465 |
An Osseointegrated Transfemoral Prosthesis Offering Long-Term Bi-Directional Efferent-Afferent Neural Transmission |
ACTIVE_NOT_RECRUITING | NA |
| NCT07516808 |
PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy |
NOT_YET_RECRUITING | NA |
| NCT07508722 |
Transcranial Ultrasonic Neuromodulation of Primary Visual Cortex and Primary Auditory Cortex in Humans |
NOT_YET_RECRUITING | NA |
| NCT07506603 |
Kenya Preschool Study |
COMPLETED | NA |
| NCT07496918 |
Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices) |
RECRUITING | PHASE2 |
| NCT07342465 |
Gamma Light and Sound Stimulation in Schizophrenia |
NOT_YET_RECRUITING | NA |
